Soham Rej, MD, MSc, FRCPC

Department of Psychiatry, Jewish General Hospital, Montreal, Quebec, Canada; Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; School of Nursing and Midwifery, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
JCP
Original Research

August 18, 2020

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs...
, , , et al
JCP
Meta-Analysis

January 21, 2020

Evidence for an effect of exercise on depression in older adults is scant and heterogeneous. This meta-analysis included trials with a specific exercise dose and assessed sources of heterogeneity—read...
, , , et al
JCP
Article

November 20, 2018

Lithium treatment, while effective for mood disorders, necessitates frequent drug level and renal monitoring in older patients to prevent serious adverse events. Read this article to see if older...
, , , et al
JCP
Original Research

August 1, 2017

Could mood-stabilizing medications be increasing patients' risk of developing kidney disease? This large, nested case-control study looks at the degree of risk associated with lithium and valproate treatment in...
, , , et al
PCC
Letter to the Editor

July 21, 2011

, ,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe